This change will take effect December 15, 2011
Overview and Clinical Utility:
Effective December 15, 2011, PathGroup will change testing kits for Toxoplasma IgM testing in house. The Platelia Toxo IgM is an in vitro diagnostic test kit allowing the qualitative detection of anti-Toxoplasma gondii in human serum or plasma (EDTA, Heparin, or Citrate). The Platelia Toxo IgM assay is presumptive for detection of anti-Toxoplasma gondii antibodies and presumptive for the diagnosis of acute, recent, or reactivated Toxoplasma gondii infection. The performance of the Platelia Toxo IgM assay has not been established for neonate testing.
Click Here to read more.